QQQ   293.34 (+1.95%)
AAPL   143.96 (+1.48%)
MSFT   248.00 (+3.07%)
META   147.30 (+4.10%)
GOOGL   97.52 (+2.42%)
AMZN   99.22 (+2.10%)
TSLA   160.27 (+10.97%)
NVDA   198.02 (+2.48%)
NIO   12.17 (+4.64%)
BABA   120.57 (+0.27%)
AMD   75.16 (+0.33%)
T   20.00 (-2.06%)
MU   62.80 (+2.05%)
F   12.92 (+1.02%)
CGC   2.76 (+0.00%)
GE   81.14 (+0.43%)
DIS   109.70 (+1.46%)
AMC   5.28 (-0.94%)
PFE   44.25 (-1.82%)
PYPL   80.81 (+2.16%)
NFLX   364.87 (-0.84%)
QQQ   293.34 (+1.95%)
AAPL   143.96 (+1.48%)
MSFT   248.00 (+3.07%)
META   147.30 (+4.10%)
GOOGL   97.52 (+2.42%)
AMZN   99.22 (+2.10%)
TSLA   160.27 (+10.97%)
NVDA   198.02 (+2.48%)
NIO   12.17 (+4.64%)
BABA   120.57 (+0.27%)
AMD   75.16 (+0.33%)
T   20.00 (-2.06%)
MU   62.80 (+2.05%)
F   12.92 (+1.02%)
CGC   2.76 (+0.00%)
GE   81.14 (+0.43%)
DIS   109.70 (+1.46%)
AMC   5.28 (-0.94%)
PFE   44.25 (-1.82%)
PYPL   80.81 (+2.16%)
NFLX   364.87 (-0.84%)
QQQ   293.34 (+1.95%)
AAPL   143.96 (+1.48%)
MSFT   248.00 (+3.07%)
META   147.30 (+4.10%)
GOOGL   97.52 (+2.42%)
AMZN   99.22 (+2.10%)
TSLA   160.27 (+10.97%)
NVDA   198.02 (+2.48%)
NIO   12.17 (+4.64%)
BABA   120.57 (+0.27%)
AMD   75.16 (+0.33%)
T   20.00 (-2.06%)
MU   62.80 (+2.05%)
F   12.92 (+1.02%)
CGC   2.76 (+0.00%)
GE   81.14 (+0.43%)
DIS   109.70 (+1.46%)
AMC   5.28 (-0.94%)
PFE   44.25 (-1.82%)
PYPL   80.81 (+2.16%)
NFLX   364.87 (-0.84%)
QQQ   293.34 (+1.95%)
AAPL   143.96 (+1.48%)
MSFT   248.00 (+3.07%)
META   147.30 (+4.10%)
GOOGL   97.52 (+2.42%)
AMZN   99.22 (+2.10%)
TSLA   160.27 (+10.97%)
NVDA   198.02 (+2.48%)
NIO   12.17 (+4.64%)
BABA   120.57 (+0.27%)
AMD   75.16 (+0.33%)
T   20.00 (-2.06%)
MU   62.80 (+2.05%)
F   12.92 (+1.02%)
CGC   2.76 (+0.00%)
GE   81.14 (+0.43%)
DIS   109.70 (+1.46%)
AMC   5.28 (-0.94%)
PFE   44.25 (-1.82%)
PYPL   80.81 (+2.16%)
NFLX   364.87 (-0.84%)
NASDAQ:PRPO

Precipio - PRPO Stock Forecast, Price & News

$0.88
-0.02 (-2.16%)
(As of 01/26/2023 04:14 PM ET)
Add
Compare
Today's Range
$0.88
$0.94
50-Day Range
$0.50
$0.91
52-Week Range
$0.47
$1.77
Volume
47,383 shs
Average Volume
141,975 shs
Market Capitalization
$20.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Precipio MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.34% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.97mentions of Precipio in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$25,950 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.45 out of 5 stars

Medical Sector

972nd out of 1,048 stocks

Analytical Instruments Industry

28th out of 28 stocks


PRPO stock logo

About Precipio (NASDAQ:PRPO) Stock

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

PRPO Stock News Headlines

Precipio Signs Another Major HemeScreen™ Customer
Stocks News Announcement
Don't miss this update. Read the press release about Small Pharma.
Precipio Signs Additional Major HemeScreen™ Customer
Precipio Announces Third Quarter Shareholder Update Call
Stocks News Announcement
Don't miss this update. Read the press release about Small Pharma.
See More Headlines
Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

PRPO Company Calendar

Last Earnings
11/10/2022
Today
1/26/2023
Next Earnings (Estimated)
3/29/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRPO
Employees
54
Year Founded
N/A

Profitability

Net Income
$-8,530,000.00
Net Margins
-128.09%
Pretax Margin
-127.93%

Debt

Sales & Book Value

Annual Sales
$8.85 million
Book Value
$1.08 per share

Miscellaneous

Free Float
20,880,000
Market Cap
$20.20 million
Optionable
Not Optionable
Beta
2.16

Key Executives

  • Ilan DanieliIlan Danieli
    Chief Executive Officer & Director
  • Ahmed Zaki SabetAhmed Zaki Sabet
    Chief Operating Officer
  • Matthew Gage
    CFO, Director-Financial Report & Analysis
  • Ayman A. Mohamed
    Vice President-Research & Development
  • Ori Karev
    Chief Strategy Officer













PRPO Stock - Frequently Asked Questions

How have PRPO shares performed in 2023?

Precipio's stock was trading at $0.5514 at the start of the year. Since then, PRPO shares have increased by 61.4% and is now trading at $0.89.
View the best growth stocks for 2023 here
.

When is Precipio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023.
View our PRPO earnings forecast
.

How were Precipio's earnings last quarter?

Precipio, Inc. (NASDAQ:PRPO) issued its earnings results on Thursday, November, 10th. The biotechnology company reported ($0.14) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $2.22 million for the quarter. Precipio had a negative net margin of 128.09% and a negative trailing twelve-month return on equity of 56.55%.

When did Precipio's stock split?

Precipio shares reverse split on the morning of Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What guidance has Precipio issued on next quarter's earnings?

Precipio issued an update on its first quarter 2023 earnings guidance on Wednesday, January, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $7.34 million-$7.34 million, compared to the consensus revenue estimate of $5.86 million.

What other stocks do shareholders of Precipio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Inpixon (INPX) and Jaguar Health (JAGX).

What is Precipio's stock symbol?

Precipio trades on the NASDAQ under the ticker symbol "PRPO."

How do I buy shares of Precipio?

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Precipio's stock price today?

One share of PRPO stock can currently be purchased for approximately $0.89.

How much money does Precipio make?

Precipio (NASDAQ:PRPO) has a market capitalization of $20.31 million and generates $8.85 million in revenue each year. The biotechnology company earns $-8,530,000.00 in net income (profit) each year or ($0.52) on an earnings per share basis.

How can I contact Precipio?

Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The official website for the company is www.precipiodx.com. The biotechnology company can be reached via phone at (203) 787-7888, via email at investors@precipiodx.com, or via fax at 402-452-5401.

This page (NASDAQ:PRPO) was last updated on 1/26/2023 by MarketBeat.com Staff